Latest news
Loading news…
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Renovacor was acquired by Rocket Pharmaceuticals in 2022.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
13
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Philadelphia, Pennsylvania, United States
- Diversity spotlight
- Women Led
Key People at Renovacor
CFO
President and CEO
Chief Scientific Advisor, Renovacor, Inc., Laura H. Carnell Professor of Medicine, cardiology
Chief Scientific Officer
13
professional contacts at Renovacor
Contact execs at Renovacor →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Renovacor
Loading news…
FAQs about Renovacor
People who checked this page also checked these
Browse the full Acquirezy directory.